Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

Clinical trial NCT04285346 · COMPLETED

Trial details

NCT number: NCT04285346
Sponsor: Marinus Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberous Sclerosis

Start date: 2020-04-08
Primary completion: 2021-06-25
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.